혹시 fda series(으)로 찾으셨나요?
뉴스
- KM Pharmaceutical Surges Despite Delisting; SK Biopharm Falls on FDA Hold [K-Bio Pulse] Korean pharmaceutical and biotech stocks showed mixed performances on Sept. 11, with KM Pharmaceutical and BL Pharmtech both hitting their daily upper price lim
- Remedi Surges, HLB Hits Limit Down as FDA Blow Weighs[K-Bio Pulse] The Korean biotech sector saw sharply diverging performances on July 13, with newly listed Remedi. emerging as the day's standout performer, while HLB extended